<DOC>
	<DOCNO>NCT01915641</DOCNO>
	<brief_summary>We report CPAP treatment improve walking capacity overlap syndrome patient . However , previous study randomize , double blind study . Therefore , design prospective , randomize , double blind , control , cross-over trial confirm finding .</brief_summary>
	<brief_title>CPAP Improves Walking Capacity Patients With COPD OSA</brief_title>
	<detailed_description>inclusion criterion : - COPD : FEV1/FVC &lt; 70 % , response bronchodilator ( FEV1 change &lt; 12 % &lt; 200ml ) - OSA : AHI &gt; 15/h , obstructive type predominant exclusion criterion : - malignancy - pregnancy - claustrophobia - age &lt; 18 primary outcome : exercise capacity ( walk distance ( meter ) , measure incremental shuttle walk test ) Method : For fit criterion . CPAP titration perform determine optimal pressure Baseline measurement : incremental shuttle walk test , urine catecholamine , heart rate variability , muscle power baseline characteristic Randomized patient group A group B group A : CPAP treatment optimal pressure 1 month , repeat measurement change CPAP treatment sham pressure 5cm H2O 1 month , repeat measurement group B : CPAP treatment sham pressure 1 month , repeat measurement change CPAP treatment optimal pressure 1 month , repeat measurement</detailed_description>
	<criteria>FEV1/FVC &lt; 70 % , response bronchodilator ( FEV1 change &lt; 12 % &lt; 200ml ) OSA : AHI &gt; 15/h , obstructive type predominant malignancy pregnancy claustrophobia age &lt; 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>walk capacity</keyword>
	<keyword>COPD</keyword>
	<keyword>OSA</keyword>
	<keyword>CPAP</keyword>
</DOC>